MedTrace Logo

Functional Electrical Stimulation Versus Whole-Body Vibration in Post-Stroke Rehabilitation

NCT07629882 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2026-06-05

No results posted yet for this study

Summary

This study will compare the effects of Functional Electrical Stimulation (FES) and Whole Body Vibration Training (WBVT) on lower limb motor control, balance, and physical performance in post-stroke patients. It will be a single-blinded randomized clinical trial including 34 participants, who will be allocated into two groups. Both groups will receive their respective interventions 4 days per week for 8 weeks. Outcomes will be assessed at baseline and after 8 weeks using the Fugl-Meyer Assessment for lower extremity motor control, Berg Balance Scale for balance, and Barthel Index for physical performance.

Conditions

  • Stroke (CVA) or TIA

Interventions

DEVICE

Whole Body Vibration Training

Whole Body Vibration Training will be delivered using a vibration platform for 8 weeks. Participants will perform progressive lower limb activities including standing, semi-squat, heel raises, dynamic squatting, side-to-side weight shifting, and one-leg stance exercises. Frequency, duration, and difficulty will be progressed according to patient tolerance under physiotherapist supervision.

DEVICE

Functional Electrical Stimulation

Functional Electrical Stimulation will be delivered transcutaneously to selected lower limb muscles for 8 weeks. Stimulation will target tibialis anterior, quadriceps, hamstrings, peroneal muscles, and other lower limb muscles according to patient need and tolerance. The intervention will use biphasic symmetrical pulsed current with progressive intensity, duration, and functional movement integration. Treatment will be supervised by a physiotherapist, and outcomes will be assessed at baseline and after 8 weeks.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Ambreen Iqbal IQBAL · Riphah International University Role

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-05
Primary Completion
2026-07-06
Completion
2026-08-06

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07629882 on ClinicalTrials.gov